等待开盘 02-05 09:30:00 美东时间
+0.160
+0.43%
Oriole Resources PLC ( ($GB:ORR) ) has shared an update. Oriole Resources PLC a...
2025-10-21 16:02
SELLAS Life Sciences (NASDAQ:SLS) traded higher in the premarket on Tuesday after the New York-based biotech said that a Phase 2 trial that tested its antitumor agent SLS009 (tambiciclib) as part of a...
2025-07-15 20:22
Orrstown Financial Services, Inc. (NASDAQ: ORRF) announced that it will report second quarter 2025 earnings on July 22, 2025, after market close. A conference call and webcast to discuss the results will be held on July 23, 2025, at 9:00 am ET. Interested parties can join via webcast or by phone using the provided toll-free numbers and conference ID 5555102. A recorded playback will be available until July 30, 2025. The company, with $5.4 billion...
2025-07-15 20:05
The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW)
2025-07-15 19:47
AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.
2025-07-11 02:36
Oriole Resources PLC ( ($GB:ORR) ) has shared an update. Oriole Resources PLC a...
2025-07-10 17:47